SCIENTIFIC PROGRAM

Joint meeting of the Czech and Austrian Head and Neck Cancer Cooperative Group

With participation of Slovak HNC Cooperative Group Preparatory Committee

Louka Monastery, Znojmo (Znaim) 7. – 8. June 2018

Znojmo

Partners of the meeting:

Partners
  • Thursday 7 June:
  • 13:00 Meeting of the CHNCCG and ATHNS Committees
  • 14:00 – 14:30 Opening, Introduction
  • History lecture: Swoboda (AT): Vltava and Danube - cradles of emergent laryngology
  • 14:30 – 15:30 Hot topics in HNC Chair: Strobl, Štefanička
  • Strobl (AT): TORS for oropharyngeal cancer: two years experience
    Štefanička (SK): Cystic neck mass in the HPV era, cystic nodal metastasis or benign cyst?
    Pink (CZ): Squamous cell cancer bone invasion in oral and oropharyngeal cancer
    Bruch (AT): Endoscopic approach in sinonasal adenocarcinoma: a single institution experience in 35 cases
  • 15:30 – 16:00 Burian (AT) HNC in the elderly
  • 16:00 – 16:30 Coffee break
  • 16:30 – 17: 30 Symposium Immunotherapy (BMS)
  • Šťastný (CZ): Escape strategies of the tumors: the role of PD–1/PD–L1 pathway
    Vošmik (CZ): Clinical Evidence for Immune Checkpoint Blockade Therapy in HN Cancer
    Klozar (CZ): Immunologic differences in HPV driven tumors – therapeutic implications?
  • Friday, 8 June
  • 9:30 – 11:00 HPV and vaccination Chair: Thurnher, Tachezy
  • Thurnher (AT): HPV in Otolaryngology including respiratory papillomatosis
    Laco (CZ): Assessment of Head and Neck Cancer – Pathological Aspects.
    Brunner (AT): Current state of deescalation in HPV positive cancers
    Tachezy (CZ): Prevention of HPV associated diseases in head and neck by prophylatic vaccination
  • 11:00 – 11:30 Coffee break
  • 11:30 – 13:30 Young scientist’s forum Chair: Pondorfer, Koucký
  • Pondorfer (AT): Soft tissue metastasis in the head & neck region, an undefined pathological  phenomenon
    Wzošová (SK): Secondary prevention in head and neck cancer – what can be done?
    Koucký (CZ): Dysfunction of HPV16-specific CD8+ T cells derived from oropharyngeal tumors is related to the expression of Tim–3 but not PD–1
    Simonidesová (CZ): Persistence of HPV–specific antibodies in head and neck cancer patients
    Weiland (AT): Detection of serological HPV16 Status in the course of therapy in patients with oropharyngeal carcinoma
    Blažková (CZ): The role of Neopterin and IL–6 salivary level in oral and oropharyngeal squamous cell carcinoma
    Ščerbová (CZ): Influence of protein Ki 67 on lymph node metastasis in oral squamous cell carcinoma.
    Kroseska (CZ): The sensitivity of imaging methods of possible cervical metastases in oral squamous cell carcinoma
  • 13:30 – 14:00 Lunch
  • 14:00 – 15:30 Proton Therapy Chair: Mock, Kubeš
  • Kříha (CZ): Proton radiotherapy – basic principles
    Mock (AT): Indications to proton therapy in Head and Neck Cancer
    Kubeš (CZ): Proton radiotherapy of HNSCC – radiation oncologists’ point of view
    Rotnáglová (CZ): Proton radiotherapy of HNSCC – otolaryngologists’ point of view
    Cwiertka (CZ): Proton therapy of head and neck cancer – We need more evidence
  • 15:30 – 16:00 Coffee break
  • 16:00 – 17:00 New insights in HNC diagnostics and treatment Chair: Zábrodský, Tedla
  • Zábrodský (CZ): Advances of diagnostic methods in HNC
    Ebner (AT): Venous routes of tumor propagation
    Tedla (SK): Management of HNC patient in Great Britain
    Dubinský (SK): Squamous cell carcinomas of the head and neck in Slovakia: perspectives of radiation oncology
  • 17:00 – 18:00 Discussion - Stump the faculty
  • 18:00 Adjourn